NASDAQ
Dermata Therapeutics, Inc. (DRMA) has a current ratio of 4.79x as of Monday, May 25, 2026. This represents a 12.43% decrease compared to its 12-month average of 5.47x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.